Clinical Trials

Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and

Iterative Health to Present AI Advancements at ECCO 2025, Highlighting Pote

Collective Insight Launches Groundbreaking Documentary on Engaging Older Ad

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Zoetis to Participate in Upcoming Investor Conferences

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with

Arima Genomics Expands Executive Team With Three Strategic Hires to Advance

Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment fo

CancerX Launches 2025 Accelerator to Drive Innovation in Oncology

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Pa

Two New Studies Demonstrate Proven Impact of Viz.ai’s Stroke Solution on

Junevity Raises $10M to Develop Cell Reset Therapeutics for Longevity

ExpressionEdits Collaborates with Boehringer Ingelheim to Develop Enhanced

Cognito Therapeutics Strengthens Executive Team to Drive Next Phase of Grow

Kenai Therapeutics Establishes Research Facility at Lilly Gateway Labs

Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leaders

Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and

New Study Highlights Positive Impact of Viz.ai on Enhancing Post-Stroke Pat

Vistagen Receives U.S. Patent for AV-101 to Treat Neuropathic Pain

Enveda Expands into Asthma with First-in-Class Lead Asset ENV-294 and Assem

Medidata Advances New Frontiers for Life Sciences Through Patient-Centric E